Related Experiment Video
Updated: Jun 11, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Knowledge Gaps, Treatment Preferences, and Unmet Clinical Needs Among Patients With Inflammatory Bowel Disease: A
Yi-Chen Wu1, Chien-Ming Chen1,2,3, Tony Kou3,4
1College of Medicine, Chang Gung University, Taoyuan City, Taiwan.
Abstract:
This study utilized a cross-sectional survey via a structured questionnaire to evaluate disease-related knowledge, treatment preferences, and unmet needs among 200 adults with confirmed inflammatory bowel disease (IBD) at a tertiary referral center. The questionnaire specifically assessed disease knowledge using the 24-item IBD-KNOW score, priorities for treatment attributes, preferred administration modalities, and self-reported unmet needs. Results indicated a mean IBD-KNOW score of 14.8/24, reflecting moderate overall knowledge, with female sex identified as an independent predictor of higher knowledge levels (OR: 1.87, p = 0.044). In terms of treatment, patients prioritized efficacy (8.9/10) over safety (8.5) and convenience (8.1); notably, 49% ranked efficacy as the most important factor, whereas 88% ranked convenience as the least important. The most preferred administration modalities were once-daily oral therapy (31%) and bimonthly subcutaneous injection (29.5%). While 43.5% of respondents reported no unmet needs, significant concerns persisted regarding the fear of disease progression (24.5%), medication cost (22.5%), and long waiting times for care (20.5%). These findings suggest that although IBD patients possess moderate disease-specific knowledge and place a strong emphasis on treatment efficacy and long-interval regimens, clinical focus is still needed to address ongoing anxieties regarding long-term outcomes, financial burdens, and healthcare access.
More Related Videos
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...